NMC.L Regulatory News (NMC)

London, 26 March 2014: NMC Health Plc ("NMC" or the "Company") (LSE:NMC), the leading independent healthcare provider operating across the United Arab Emirates, announces that Mr Khalifa Bin Butti has decided to step down from the Board with effect from 25 March 2014.

Khalifa Bin Butti has been an Executive Director of NMC Health since 2011, and played a key role in bringing the Company onto the premium segment of the London Stock Exchange in April 2012. Since then he has served as Executive Vice Chairman and Director on the Board, helping steer the Company through a successful first two years as a public entity. Now that the Company is established as a successful listed entity with an impressive record of improving results he has decided to step down from the Board.

Mark Tompkins, Chairman of NMC Health commented:

'The Board would like to thank Khalifa Bin Butti for his significant contribution over the last three years. Khalifa played an integral part of the successful IPO by which NMC Health plc became the first UAE business to list on the premium segment of the London Stock Exchange in April 2012. His assistance to myself and to the rest of the Board through the Company's first two years of growth on the public markets has been invaluable.'

Contacts

Investors:

Roy Cherry, Head of Strategy and Investor Relations +971 50 667 0184

Media:

Brunswick UK

Justine McIlroy/Azadeh Varzi

+44 20 7404 5959

Brunswick Gulf

Steve Martin Wajih Halawa

+971 5 6696 9232 +971 5 0100 9207

About NMC

NMC Health plc group is the leading integrated private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Healthcare Division currently operates or manages five hospitals, two day-care patient centres, one medical centre and eight pharmacies. The company received 2.1m patients in 2013. The group also operates a significant UAE wide Distribution business supplying product lines across several key market segments, including: Pharmaceutical, FMCG, Food and Scientific and Medical Equipment. NMC Health plc group reported revenues of US$ 550.9m in 2013.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. At the time of its IPO, the group raised funds to enable it to pursue a further growth plan with a number of capital projects for new healthcare facilities in Abu Dhabi and Dubai. NMC Health plc is a constituent of the FTSE 250 Index.